Forschung & Innovation
Publikationen
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.
PMU Autor*innen
Johann Sellner, Eva Rohde, Mario Gimona, Dirk Strunk
Alle Autor*innen
Antonio Uccelli, Alice Laroni, Lou Brundin, Michel Clanet, Oscar Fernandez, Seyed Massood Nabavi, Paolo A Muraro, Roberto S Oliveri, Ernst W Radue, Johann Sellner, Per Soelberg Sorensen, Maria Pia Sormani, Jens Thomas Wuerfel, Mario A Battaglia, Mark S Freedman, , Eva Rohde, Mario Gimona, Dirk Strunk
Fachzeitschrift
Trials
Kurzfassung
Keywords
TRANSPLANTATION, NEUROLOGICAL DISEASES, EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS